Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-119973
Filing Date
2026-03-23
Accepted
2026-03-23 17:10:37
Documents
22

Document Format Files

Seq Description Document Type Size
1 S-3 ck0001774857-20260323.htm S-3 903031
2 EX-1.2 ck0001774857-ex1_2.htm EX-1.2 344597
3 EX-4.2 ck0001774857-ex4_2.htm EX-4.2 605634
4 EX-5.1 ck0001774857-ex5_1.htm EX-5.1 69125
5 EX-23.1 ck0001774857-ex23_1.htm EX-23.1 4631
6 EX-FILING FEES ck0001774857-exfiling_fees.htm   iXBRL EX-FILING FEES 40163
7 GRAPHIC img8190679_0.jpg GRAPHIC 27677
8 GRAPHIC img8190679_1.gif GRAPHIC 429930
9 GRAPHIC img8190679_2.jpg GRAPHIC 27677
10 GRAPHIC img8190679_3.gif GRAPHIC 429930
11 GRAPHIC img8190679_4.jpg GRAPHIC 27677
12 GRAPHIC img82710889_0.jpg GRAPHIC 28888
13 GRAPHIC img82710889_1.jpg GRAPHIC 9762
  Complete submission text file 0001193125-26-119973.txt   3452109

Data Files

Seq Description Document Type Size
25 EXTRACTED XBRL INSTANCE DOCUMENT ck0001774857-exfiling_fees_htm.xml XML 11830
Mailing Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DRIVE SUITE 1050 SAN DIEGO CA 92122 (858) 225-7696
Aardvark Therapeutics, Inc. (Filer) CIK: 0001774857 (see all company filings)

EIN.: 821606367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-294537 | Film No.: 26783197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)